FMR1 and fragile X syndrome: To define mislocalized genes, we therefore used a log2 fold change cutoff of 0.25 to define genes whose neurite-localization decreased in FXS (FMRP targets) or increased in FXS (FMRP nontargets) (Figure 3—figure supplement 6).